Recording Electrically-Evoked Auditory Brainstem Responses in a Deafened Mouse
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:43 min • July 8th, 2025
Loading...
Overview
This article details a surgical procedure for cochlear implantation in a deafened mouse model. It outlines the steps for inserting an electrode array into the cochlea and recording auditory brainstem responses (ABR).
Key Study Components
Area of Science
- Neuroscience
- Auditory research
- Electrophysiology
Background
- Cochlear implants are used to restore hearing in deaf individuals.
- Understanding the implantation process is crucial for effective auditory rehabilitation.
- ABR is a key measure for assessing auditory function post-implantation.
- Animal models are essential for studying cochlear implant efficacy.
Purpose of Study
- To demonstrate the surgical technique for cochlear implantation in mice.
- To outline the process for recording ABR responses post-implantation.
- To provide a detailed methodology for researchers in auditory neuroscience.
Methods Used
- Incision made behind the ear to access the bulla.
- Insertion of a cochlear implant electrode array into the scala tympani.
- Coiling and securing of the lead wire inside the bulla.
- Application of electrical stimuli and recording of ABR responses.
Main Results
- Successful insertion of the electrode array was achieved.
- ABR responses were recorded following electrical stimulation.
- The methodology allows for reproducible results in auditory research.
- Findings contribute to the understanding of cochlear implant functionality.
Conclusions
- The surgical technique is effective for cochlear implantation in mice.
- ABR recordings provide valuable data on auditory processing.
- This study serves as a guide for future research in auditory neuroscience.
Frequently Asked Questions
What is the purpose of a cochlear implant?
Cochlear implants are designed to provide a sense of sound to individuals who are profoundly deaf or severely hard of hearing.
How is the electrode array inserted?
The electrode array is inserted through the round window into the scala tympani of the cochlea.
What is ABR?
Auditory brainstem response (ABR) is an electrophysiological measure used to assess hearing by recording brain activity in response to sound.
Why use a mouse model for this study?
Mouse models are commonly used in research to study auditory mechanisms and the effects of cochlear implants due to their genetic manipulability.
What are the key steps in the surgical procedure?
Key steps include making an incision, inserting the electrode array, coiling the lead wire, and securing the implant.
What are the implications of this research?
This research provides insights into cochlear implant procedures and can help improve auditory rehabilitation strategies.
Executive Industry Relevance
This protocol enables preclinical evaluation of cochlear implant functionality using electrically-evoked auditory brainstem responses in a deafened mouse model. It supports target validation and mechanistic de-risking by providing quantitative neurophysiological readouts of auditory pathway engagement. The approach aids in lead identification and predictive confidence for auditory prosthetics development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses regarding electrical stimulation efficacy in auditory pathways.
- Operational Value: Enables biological de-risking through functional target validation of cochlear implant designs.
- Predictive Value: Supports portfolio triage by assessing neural response thresholds and waveform morphology.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for downstream compound or device screening.
- Quantitative Outputs: Provides reproducible, electrically-evoked ABR measurements for standardized screening.
- Platform Reuse: Facilitates scalable evaluation of electrode configurations and stimulation parameters.
Translational & Preclinical Research
- Disease Relevance: Uses a deafened mouse model to mirror clinical auditory neuropathy conditions.
- Translational Continuity: Bridges discovery through preclinical validation via consistent electrophysiological endpoints.
- Risk-Adjusted Decisions: Informs advancement based on ABR amplitude, latency, and threshold shifts.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through lead identification to preclinical assessment of auditory prosthetics.
- Discovery Biology: Supports hypothesis testing of electrical stimulation effects on neural pathway activation.
- Screening: Enables assay readiness through standardized electrode placement and stimulation paradigms.
- Analytics: Delivers quantitative dependent variable measurements (wave I-V amplitudes, latencies) for condition comparison.
- Translational Research: Connects to preclinical continuity via ABR as a translational biomarker of auditory function.
- Enterprise Reuse: Establishes a reusable electrophysiological platform for iterative device optimization.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target engagement, reduction of mechanistic ambiguity in auditory processing.
- Operational Value: Standardization of surgical and recording procedures, reproducibility across operators.
- Strategic Value: Better go/no-go decisions on implant designs, capital efficiency in early-stage validation.
- Portfolio Impact: Risk-adjusted prioritization based on electrophysiological response profiles.
Implementation Considerations
- Requires expertise in microsurgery, electrophysiology, and auditory neuroscience.
- Depends on stimulation platforms, headstage pre-amplifiers, and auditory processing systems.
- Necessitates cross-team standardization of electrode placement, stimulus parameters, and ABR acquisition protocols.
- Involves adaptation considerations across mouse strains, deafening methods, and electrode array designs.
- Practical limitations include surgical variability in electrode placement and signal-to-noise challenges in evoked response detection.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in eABR studies?
Null hypothesis testing determines whether observed electrically-evoked ABR responses significantly differ from baseline noise, confirming true neural activation rather than artifact. This statistical validation supports target validation by establishing that electrical stimulation reliably engages the auditory pathway. It provides a quantitative threshold for go/no-go decisions in target confirmation.
How does independent variable isolation fit the discovery pipeline for cochlear implant evaluation?
Isolating the independent variable—such as stimulus amplitude or electrode position—allows researchers to attribute changes in eABR responses directly to specific manipulation. This control is essential in early discovery to clarify dose-response relationships and mechanism of action. It enables precise structure-activity or structure-function analysis during lead identification.
What quantitative dependent variable measurements enable preclinical assessment of auditory prosthetics?
Dependent variables include eABR wave amplitudes (particularly wave I), latencies, and threshold levels, which quantify auditory nerve synchrony and conduction velocity. These measurements enable objective comparison across implant designs, stimulation parameters, or pharmacological conditions. They serve as translatable biomarkers for predicting clinical auditory outcomes.
Why do replication requirements matter for cross-functional collaboration in electrophysiology studies?
Replication ensures that eABR results are consistent across operators, sessions, and laboratories, reducing variability that could confound interpretation. This reliability is critical for cross-functional teams in discovery, translational, and preclinical units to align on go/no-go criteria. Standardized replication supports data integrity and regulatory-style documentation in IND-enabling studies.
What statistical analysis capabilities are required before implementing eABR in auditory research workflows?
Required capabilities include threshold determination via response growth functions, ANOVA for group comparisons, and confidence interval estimation for wave amplitude and latency. These analyses enable teams to assess statistical significance, effect size, and reproducibility of electrically-evoked responses. Implementation depends on access to biostatistical support or validated analysis pipelines for electrophysiological data.
09:23
Auditory Brainstem Response and Outer Hair Cell Whole-cell Patch Clamp Recording in Postnatal Rats
Related Videos
0 Views
09:29
Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
Related Videos
0 Views
09:32
Evaluation of Auditory Brainstem Response in Chicken Hatchlings
Related Videos
0 Views
14:06
Preparation of an Awake Mouse for Recording Neural Responses and Injecting Tracers
Related Videos
0 Views
02:38
Recording Auditory Brainstem Responses in a Rat Pup
Related Videos
0 Views
02:58
Investigating Auditory Neuronal Responses in an Awake Mouse in the Presence of an Inhibitory Neurotransmitter Blocker
Related Videos
0 Views
02:22
Measuring the Auditory Brainstem Response in Mice
Related Videos
0 Views
09:18
A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Related Videos
0 Views
09:06
Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
Related Videos
0 Views
09:54
Morphological and Functional Evaluation of Ribbon Synapses at Specific Frequency Regions of the Mouse Cochlea
Related Videos
0 Views
Last updated: 1 August 2026